Status:
COMPLETED
Prognostic Factors for Acute Pulmonary Embolism in Critically Ill Patients
Lead Sponsor:
Yonsei University
Conditions:
Acute Pulmonary Embolism (PE)
Eligibility:
All Genders
34+ years
Brief Summary
Acute pulmonary embolism (PE) is an important cause of in-hospital mortality and may be rapidly fatal if not diagnosed and treated. Despite recent advances in diagnostic and therapeutic modalities, it...
Eligibility Criteria
Inclusion
- patients admitted to the Severance Hospital, Yonsei University Health System with primary diagnosis of PE between January 2008 and December 2012. (diagnosed by CT and treated in the hospital with IV unfractionated heparin)
Exclusion
- diagnosis was prior to arrivalor
- anticoagulation was contraindicated
- diagnosis was not confirmed by CT
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01839266
Start Date
November 1 2011
End Date
April 1 2013
Last Update
April 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Chief of ICUs, Severance Hospital, Yonsei University Health System
Seoul, Seoul, South Korea, 120-752